HNO International (HNOI) EBITDA Margin (2022 - 2025)
HNO International filings provide 4 years of EBITDA Margin readings, the most recent being 547.41% for Q4 2025.
- On a quarterly basis, EBITDA Margin changed N/A to 547.41% in Q4 2025 year-over-year; TTM through Jan 2026 was 1647.74%, a 18987716.0% increase, with the full-year FY2025 number at 9727.13%, up 6534048.0% from a year prior.
- EBITDA Margin hit 547.41% in Q4 2025 for HNO International, up from 943.82% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 547.41% in Q4 2025 to a low of 10693.07% in Q3 2024.
- Median EBITDA Margin over the past 4 years was 1566.02% (2023), compared with a mean of 3180.29%.